Israeli student develops drug-delivering skin gel; Nanorobots offer delivery at the atomic level;

> A student at the Hebrew University of Jerusalem has developed a gel made of lyotropic liquid crystals for the application of drugs directly to the skin where oral drugs can cause severe side effects. Marganit Cohen-Avrahami won one of this year's Kaye Innovation Awards for her work. Report

> Scientific American, in its "30 Under 30" report highlighting young scientists, interviewed Aniket Magarkar, who studies liposomes that could help develop nanorobots capable of delivering drugs. Report

> Alchemy Pharmatech snagged a £400,000 investment from the North West Fund for its intranasal drug-delivery system for DNA vaccines, hormone replacement compounds and pain-control products. Release

> Access Pharmaceuticals ($ACCP) signed a licensing agreement with AMAG Pharmaceuticals ($AMAG) for $3.3 million to market its MuGard, a mucoadhesive treatment for oral wounds. Release

> Discovery Labs ($DSCO) presented an analysis that showed its Surfaxin treatment for infant respiratory distress syndrome, the first synthetic, peptide-containing surfactant approved by the FDA, could save up to $562,000 per 100 patients. Release

Suggested Articles

Genentech's Port Delivery System with ranibizumab matched Lucentis eye injections in a late-stage, wet age-related macular degeneration trial.

Astex's oral reformulation of a common chemo combo looks to replace lengthy infusions with a once-daily tablet that patients can take at home.

Teva is diving into the U.S. digital health market with the launch of its ProAir Digihaler—an albuterol dispenser that tracks patient use data.